BJRI
BJ's Restaurants, Inc.
BJRI has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
BJRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
BJRI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BJRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $42.55 | -22% |
| Current | 26x | $54.89 | — |
| Fair | 32x | $66.37 | +21% |
| Expensive | 51x | $108 | +96% |
Historical ranges are pointers, not guarantees.
BJRI's PE is in its cheap range at 26x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BJRI Forward outlook
There aren't enough analyst estimates for BJRI to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BJRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.10 | +54% |
| Q2 2026 | $1.88 | +55% |
| Q1 2026 | $1.99 | +107% |
| Q4 2025 | $2.16 | +209% |
| Q3 2025 | $1.36 | +9.7% |
| Q2 2025 | $1.21 | 0% |
| Q1 2025 | $0.96 | -3% |
| Q4 2024 | $0.70 | -15% |
BJRI has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BJRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $358.6M | +8.6% |
| Q2 2026 | $388.9M | +6.4% |
| Q1 2026 | $358.1M | +2.9% |
| Q4 2025 | $355.4M | +3.2% |
| Q3 2025 | $330.2M | +1.4% |
| Q2 2025 | $365.6M | +4.5% |
| Q1 2025 | $348M | +3.2% |
| Q4 2024 | $344.3M | +6.4% |
BJRI's revenue has grown year over year for 10 quarters in a row: $359M last quarter, up 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +1.8 points |
| Q2 2026 | 4.7% | -1.1 points |
| Q1 2026 | 3% | -1.3 points |
| Q4 2025 | 3.1% | +4.5 points |
| Q3 2025 | -0.3% | +0.5 points |
| Q2 2025 | 5.8% | +2 points |
| Q1 2025 | 4.3% | +1.8 points |
| Q4 2024 | -1.4% | -2.4 points |
BJRI has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BJRI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BJRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.2M | +515% |
| Q2 2026 | $7.7M | -82% |
| Q1 2026 | $27.2M | +$39.2M |
| Q4 2025 | $7.5M | -53% |
| Q3 2025 | $3.6M | -53% |
| Q2 2025 | $41.9M | +5601% |
| Q1 2025 | -$12.1M | -2792% |
| Q4 2024 | $15.8M | +3.1% |
BJRI has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BJRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 0.5x | Very low |
BJRI's net debt is less than a year of its operating earnings (EBITDA).
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BJRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 16.3 | Oversold |
BJRI's weekly RSI is 47 (neutral) and its Stochastic is 16 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BJRI PE vs Consumer Cyclical Sector
| Metric | BJRI | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 45% above |
| PE % | 27 | 47 | 20 pts below |
BJRI is trading at 26x earnings, a 45% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BJRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.9 | 6.7% below |
| 20 week MA | $62.2 | 12% below |
| 50 week MA | $49.9 | 10% above |
| 100 week MA | $43.1 | 27% above |
| 200 week MA | $37.7 | 46% above |
BJRI has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BJRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.4 | $39.1 | +4.5% |
| 2021 | $39.1 | $36.1 | -7.6% |
| 2022 | $36.1 | $27.8 | -23% |
| 2023 | $27.8 | $36.0 | +30% |
| 2024 | $36.0 | $34.7 | -3.5% |
| 2025 | $34.7 | $41.2 | +19% |
| 2026 YTD | $41.2 | $54.9 | +33% |
BJRI has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.